Global Head Lice Infestation Drug Revenue Is Nearly 393 M USD In 2017
Wednesday, 31 Oct, 2018
In the last several years, global market of Head Lice Infestation Drug developed stable, with an average growth rate of 5.48%. In 2017, global revenue of Head Lice Infestation Drug is nearly 393 M USD; the actual sales are about 44.9 M unit.

The Global Main Head Lice Infestation Drug Manufacturers are Perrigo, Bayer, Prestige Brands, Stada Arzneimittel, Alliance Pharma Inc., TecLabs and other manufacturers. Perrigo is one of the largest manufacturers in the global Head Lice Infestation Drug market with10% market share in 2017, followed by Bayer with 8.99% marke share.  

The Head Lice Infestation Drug sales regions are mainly North America and Europe. Europe is the largest region to consumption Head Lice Infestation Drug occupied about 36% market share in 2017, followed by North America with 32% market share

The classification of Head Lice Infestation Drug includes Lotion, Creams, Shampoo and Other type. And the proportion of Lotion in 2017 is about 31%, and the proportion is stable d from 2013 to 2017.

Head Lice Infestation Drug is widely used for Children and Ault. The most proportion of Head Lice Infestation Drug is for Children and the proportion in 2017 is 90 

After a long investigation and research, we think people are very concerned about the Head Lice Infestation Drug content in the daily commodities. We recommend that some manufacturers would add Head Lice Infestation Drug to satisfy the market demanding for all household members and other close to head lice contacts should be checked.